Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24399198)

1.

Delayed intravenous thrombolysis based on MRI mismatch in posterior circulation stroke.

Deprez N, De Herdt V, Vandersteene J, Acou M, Defreyne L, Hemelsoet D.

Acta Neurol Belg. 2014 Jun;114(2):113-5. doi: 10.1007/s13760-013-0271-x. Epub 2014 Jan 8.

PMID:
24399198
2.

Total mismatch in anterior circulation stroke patients before thrombolysis.

Fustier A, Naggara O, Tisserand M, Touzé E, Mellerio C, Edjlali M, Malherbe C, Roca P, Baron JC, Mas JL, Méder JF, Oppenheim C.

J Neuroradiol. 2013 Jul;40(3):158-63. doi: 10.1016/j.neurad.2013.03.001. Epub 2013 Jun 24.

3.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

4.

Total mismatch: negative diffusion-weighted imaging but extensive perfusion defect in acute stroke.

Cho TH, Hermier M, Alawneh JA, Ritzenthaler T, Desestret V, Østergaard L, Derex L, Baron JC, Nighoghossian N.

Stroke. 2009 Oct;40(10):3400-2. doi: 10.1161/STROKEAHA.109.563064. Epub 2009 Aug 20.

5.

Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset.

Han MK, Kim SH, Ko SB, Paik NJ, Kwon OK, Lee YS, Oh CW, Kim JH, Park SH, Bae HJ.

Neurocrit Care. 2008;8(3):353-9. doi: 10.1007/s12028-007-9046-7.

PMID:
18340411
6.

SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.

Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.

Exp Neurol. 2008 Jul;212(1):53-62. doi: 10.1016/j.expneurol.2008.03.011. Epub 2008 Mar 25.

PMID:
18462720
7.

Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.

García-Bermejo P, Calleja AI, Pérez-Fernández S, Cortijo E, del Monte JM, García-Porrero M, Fe Muñoz M, Fernández-Herranz R, Arenillas JF.

Cerebrovasc Dis. 2012;34(1):31-7. doi: 10.1159/000338778. Epub 2012 Jun 29.

PMID:
22759450
8.

Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis.

Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA, Ebinger M, Barber PA, Bladin C, Donnan GA, Davis SM; Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators.

J Cereb Blood Flow Metab. 2010 Jun;30(6):1214-25. doi: 10.1038/jcbfm.2010.3. Epub 2010 Jan 20.

9.

Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.

Deguchi I, Takeda H, Furuya D, Dembo T, Nagoya H, Kato Y, Ito Y, Fukuoka T, Maruyama H, Tanahashi N.

J Stroke Cerebrovasc Dis. 2012 Feb;21(2):108-13. doi: 10.1016/j.jstrokecerebrovasdis.2010.03.019. Epub 2010 Sep 19. Erratum in: J Stroke Cerebrovasc Dis. 2012 May;21(4):342.

PMID:
20851627
10.
11.
12.

Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE).

Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, Wechsler L, Gold GE, Bammer R, Marks MP, Albers GW.

Stroke. 2009 Oct;40(10):3245-51. doi: 10.1161/STROKEAHA.109.558635. Epub 2009 Aug 13.

13.

The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics.

Tatlisumak T, Strbian D, Abo Ramadan U, Li F.

Curr Vasc Pharmacol. 2004 Oct;2(4):343-55. Review.

PMID:
15320814
14.

Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.

Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, Pohlers O, Ryssel H, Sartor K, Hacke W.

Stroke. 2000 Jun;31(6):1318-28.

15.

Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI.

Rordorf G, Koroshetz WJ, Copen WA, Cramer SC, Schaefer PW, Budzik RF Jr, Schwamm LH, Buonanno F, Sorensen AG, Gonzalez G.

Stroke. 1998 May;29(5):939-43.

16.

Seizure at stroke onset: should it be an absolute contraindication to thrombolysis?

Selim M, Kumar S, Fink J, Schlaug G, Caplan LR, Linfante I.

Cerebrovasc Dis. 2002;14(1):54-7.

PMID:
12097852
17.

Diffusion- and perfusion-weighted MRI: influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke.

Neumann-Haefelin T, Wittsack HJ, Fink GR, Wenserski F, Li TQ, Seitz RJ, Siebler M, Mödder U, Freund HJ.

Stroke. 2000 Jun;31(6):1311-7.

18.

Refining the perfusion-diffusion mismatch hypothesis.

Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, Levi C, Kimber T, Schultz D, Fink J, Tress B, Donnan G, Davis S; EPITHET Investigators.

Stroke. 2005 Jun;36(6):1153-9.

19.

Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke.

Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, Parsons MW.

Stroke. 2012 Oct;43(10):2648-53. Epub 2012 Aug 2.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk